Exane Derivatives’s Banco Bradesco BBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,822
Closed -$42.9K 660
2019
Q2
$42.9K Buy
+5,822
New +$39.8K 0.01% 399
2019
Q1
Sell
-19,106
Closed -$118K 671
2018
Q4
$118K Sell
19,106
-153,970
-89% -$894K 0.02% 304
2018
Q3
$777K Sell
173,076
-1,785
-1% -$8.23K 0.15% 129
2018
Q2
$758K Buy
174,861
+174,859
+8,742,950% +$949K 0.13% 144
2018
Q1
$11 Hold
2
﹤0.01% 618
2017
Q4
$10 Sell
2
-1,163
-100% -$6.97K ﹤0.01% 602
2017
Q3
$7.34K Sell
1,165
-7,976
-87% -$46.3K ﹤0.01% 419
2017
Q2
$44.2K Buy
9,141
+9,139
+456,950% +$46.4K 0.01% 322
2017
Q1
$10 Sell
2
-43,729
-100% -$231K ﹤0.01% 560
2016
Q4
$197K Buy
43,731
+32,798
+300% +$154K 0.04% 202
2016
Q3
$51.3K Sell
10,933
-25,325
-70% -$115K 0.01% 300
2016
Q2
$147K Sell
36,258
-21,145
-37% -$77.8K 0.02% 219
2016
Q1
$201K Buy
+57,403
New +$149K 0.03% 194
2015
Q4
Sell
-187,627
Closed -$473K 525
2015
Q3
$473K Buy
187,627
+109,123
+139% +$368K 0.06% 127
2015
Q2
$338K Buy
78,504
+28,412
+57% +$131K 0.04% 173
2015
Q1
$219K Buy
50,092
+41,385
+475% +$203K 0.02% 199
2014
Q4
$45.6K Buy
+8,707
New +$48.8K 0.01% 329

Other funds holding BBD

Exane Derivatives's BBD Position: Q3 2019 in Review

Exane Derivatives sold out of Banco Bradesco (BBD) in Q3 2019, closing a stake of 5,822 shares — an estimated $42.9K sold.

Exane Derivatives first reported a position in BBD in Q4 2014 and held it in 17 quarters. The position peaked at $777K in Q3 2018. 215 funds tracked by Wall St. Rank hold BBD as of Q3 2019.

  • Exane Derivatives reported no remaining Banco Bradesco position as of Q3 2019 after selling out during the quarter.
  • Exane Derivatives sold 5,822 Banco Bradesco shares in Q3 2019, an estimated $42.9K.
  • Exane Derivatives first reported a position in Banco Bradesco in Q4 2014 and held it in 17 quarters.
  • Exane Derivatives's Banco Bradesco position peaked at $777K in Q3 2018.
  • 215 funds tracked by Wall St. Rank held Banco Bradesco as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.